IMNPQ Stock Price | Immune Pharmaceuticals Inc. Stock ... Immune Pharmaceuticals Inc. Immune Pharmaceuticals, Inc. is a biopharmaceutical company developing novel therapeutic agents for the treatment of immunologic and inflammatory diseases. IMNPQ - Immune Pharmaceuticals Inc Stock quote - … Find real-time IMNPQ - Immune Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business. IMNP Stock Price, Forecast & News (Immune Pharmaceuticals) Based on aggregate information from My MarketBeat watchlists, some companies that other Immune Pharmaceuticals investors own include Neovasc (NVCN), CytRx (CYTR), Synergy Pharmaceuticals (SGYP), Biopharmx (BPMX), Gevo (GEVO), Pernix Therapeutics (PTX), Novavax (NVAX), DryShips (DRYS), Heat Biologics (HTBX) and Molecular Templates (MTEM). IMNP Stock Quote - Immune Pharmaceuticals Inc - Bloomberg ...
IMNP - Immune Pharmaceuticals News - Barchart.com Immune Pharmaceuticals, Inc. (OTCQB: IMNP) ("Immune" or the "Company"), a biopharmaceutical company developing novel therapeutic agents for the treatment of immunologic and inflammatory diseases, has filed IMNP: NA - Price & Consenus Chart - Zacks.com Immune Pharmaceuticals Inc. (IMNP) Quote Overview » Charts » Immune Pharmaceuticals Inc. (IMNP) Price and Consensus Price and Consensus The Style Scores are a complementary set of indicators to
Securities products and services offered to self-directed investors through ST Invest, LLC. Member FINRA / SIPC.ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. Please read important legal disclosures. - IMNP - Stock Price Today - Zacks Investment Research
Immune Pharma (IMNP) Announces Corporate Restructuring ... Immune Pharmaceuticals Inc. (NASDAQ: IMNP) announced a major corporate restructuring with the objective of prioritizing and segregating its research and development efforts on a focused set of Immune Pharmaceuticals Inc. - IMNP | Stock Market Immune Pharmaceuticals Inc. (OTCBB:IMNP) has a Market Cap of 10.79M and a book value of common share of -0.01, and an Earning/Share (EPS) of -4.74.The 52-week high was $8.16, while the 52-week low was $1.02.. To make any decision of buying or selling or holding you need to consider the company's situation today as well as its history and future prospect. StockNewsNow.com Publishes Q3 2015 Review SNNLive Video ... Nov 02, 2015 · StockNewsNow.com, The Official MicroCap News Source™, today published an SNNLive Video Interview with Dr. Daniel Teper, CEO of Immune Pharmaceuticals, Inc. , …
NEW YORK, April 12, 2017 /PRNewswire/ -- Immune Pharmaceuticals Inc. (Nasdaq: IMNP) ("Immune" or the "Company"), today announced a reverse stock split of its shares of common stock at a ratio of 1-for-20. Beginning with the opening of trading on April 13, 2017, the Company's common stock will continue to trade The Nasdaq Capital Market ("Nasdaq") under the symbol "IMNP," but will trade on a StockNewsNow.com Publishes New SNNLive Video Interview ... Jun 25, 2015 · StockNewsNow.com, The Official MicroCap News Source™, today published an SNNLive Video Interview with Dr. Daniel Teper, CEO of Immune Pharmaceuticals, Inc. , … Immune Pharma (IMNP) to Trade on 1-for-20 Reverse Split ... Immune Pharma (IMNP) to Trade on 1-for-20 Reverse Split-Adjusted Basis on April 13. Immune Pharmaceuticals Inc. Immune has until May 1, 2017 to regain compliance with …